Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction
Abstract Chronic Lung Allograft Dysfunction (CLAD), manifesting as Bronchiolitis Obliterans Syndrome (BOS) or Restrictive Allograft Syndrome (RAS), is the main reason for adverse long-term outcome after Lung Transplantation (LTX). Until now, no specific biomarkers exist to differentiate between CLAD...
Guardado en:
Autores principales: | Cecilia Veraar, Jonathan Kliman, Alberto Benazzo, Felicitas Oberndorfer, Maria Laggner, Philipp Hacker, Thomas Raunegger, Stefan Janik, Peter Jaksch, Walter Klepetko, Hendrik J. Ankersmit, Bernhard Moser |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b1d018156f434affb0f33f57f6b74138 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Short-term azithromycin treatment promotes cornea allograft survival in the rat.
por: Katrin Wacker, et al.
Publicado: (2013) -
Etiological and Clinical Evaluations of Patients with Acute Allograft Dysfunction Within the First Year Address
por: Eren Soyaltın, et al.
Publicado: (2021) -
Plasma Acute Phase Proteins as Predictors of Chronic Lung Allograft Dysfunction in Lung Transplant Recipients
por: Janciauskiene S, et al.
Publicado: (2020) -
Respiratory metapneumoviral infection without co-infection in association with acute and chronic lung allograft dysfunction
por: Dosanjh A
Publicado: (2015) -
Preservation of epoxyeicosatrienoic acid bioavailability prevents renal allograft dysfunction and cardiovascular alterations in kidney transplant recipients
por: Thomas Duflot, et al.
Publicado: (2021)